A detailed history of State Of Wisconsin Investment Board transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 58,111 shares of TVTX stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,111
Previous 279,104 79.18%
Holding current value
$1.01 Million
Previous $2.29 Million 64.6%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.89 - $15.21 $1.74 Million - $3.36 Million
-220,993 Reduced 79.18%
58,111 $812,000
Q2 2024

Aug 14, 2024

BUY
$5.26 - $8.28 $823,568 - $1.3 Million
156,572 Added 127.78%
279,104 $2.29 Million
Q1 2024

May 14, 2024

BUY
$7.18 - $9.82 $210,725 - $288,207
29,349 Added 31.5%
122,532 $944,000
Q4 2023

Feb 12, 2024

BUY
$5.44 - $9.5 $211,180 - $368,790
38,820 Added 71.41%
93,183 $837,000
Q3 2023

Nov 14, 2023

SELL
$7.64 - $17.25 $57,941 - $130,824
-7,584 Reduced 12.24%
54,363 $486,000
Q2 2023

Aug 14, 2023

BUY
$15.3 - $22.61 $211,629 - $312,741
13,832 Added 28.75%
61,947 $951,000
Q1 2023

May 15, 2023

SELL
$17.82 - $22.89 $77,784 - $99,914
-4,365 Reduced 8.32%
48,115 $1.08 Million
Q4 2022

Feb 14, 2023

SELL
$18.47 - $26.14 $60,766 - $86,000
-3,290 Reduced 5.9%
52,480 $1.1 Million
Q3 2022

Nov 14, 2022

SELL
$22.91 - $28.63 $74,915 - $93,620
-3,270 Reduced 5.54%
55,770 $1.37 Million
Q2 2022

Aug 15, 2022

SELL
$20.94 - $30.01 $417,962 - $598,999
-19,960 Reduced 25.27%
59,040 $1.43 Million
Q1 2022

May 13, 2022

BUY
$23.61 - $30.6 $245,544 - $318,240
10,400 Added 15.16%
79,000 $2.04 Million
Q4 2020

Feb 03, 2021

BUY
$19.17 - $27.87 $1.32 Million - $1.91 Million
68,600 New
68,600 $1.87 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.